Latest filing published 30 Aug 2024 for Immunovia, €333.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Martin Moeller: trading record in brief
All filings by Martin Moeller on record concern Immunovia. The record holds 3 filings, for trades running from 2 September 2021 to 30 August 2024.
On the market, this insider has only ever bought: 1 purchase, €14k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 30 August 2024 came the latest disclosure, a transaction for €333 in Immunovia. The most recent open-market purchase was published on 3 September 2021, 1,892 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin Moeller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,696 shares@ SEK 1.022.2% of flowBTU (betald tecknad unit)ISIN SE0022600128FI:csv-b819d3c4f1cf19d8c936
- 1,408 shares@ SEK 6.705.6% of flowAktieISIN SE0006091997FI:csv-076c312403e6dfb37bd6
- 1,056 shares@ SEK 133.8092.2% of flowAktieISIN SE0006091997FI:csv-a12bb79dd68b12c59b9fCanonical exit: 1 Dec 2021 (T+90)
3 of 3 declarations